Myostatin (MSTN), a member of the transforming growth factor-b superfamily, has been shown to be a negative regulator of myogenesis. Natural mutation in beef cattle causes double-muscling phenotypes. We report an investigation designed to knockout the MSTN gene by gene targeting in ovine myoblast cells. Two promoter-trap targeting vectors MSTN-green fluorescent protein (GFP) and MSTN-neo were constructed and used to transfect foetal and neonatal ovine primary myoblast cells. Both GFP-expressing cells and drug-resistant cells were obtained. Targeted cells expressing GFP were confirmed by polymerase chain reaction (PCR) assay and drug-resistant cells were characterised by PCR and Southern blot after growing into cell clones.
Introduction
Over the past 20 years, it has been possible to make essentially any mutation in the germline of mice by using recombination and embryonic stem cells (Joyner et al., 1989) . The extension of this technique to other mammalian species might bring numerous benefits in biomedicine and agriculture (McCreath et al., 2000) . However, gene-targeting methodology developed in mice may not be suitable for livestock because functional embryonic stem cells have not been proven and because production of homologous targeted loci would take a much longer time. McCreath et al. (2000) reported that locus-modified live lambs were produced using stepwise gene targeting in cultured ovine foetal fibroblast cells followed by using targeted cells as a nuclear donor in somatic cloning. Their work has immediately paved a way for genome modification in farm animals.
The myostatin (MSTN) gene is a specific negative regulator of skeletal muscle mass. It has been well known that cattle breeds carrying mutated myostatin allele have overdeveloped muscles (Kambadur et al., 1997) . In recent years, studies in the mouse model have indicated that a high expression of pro-domain of MSTN gene in transgenic mice could lead to enhanced growth of muscle mass (Yang et al., 2001) . Knocking out the mouse MSTN gene resulted in a mouse with almost doubled muscle mass (McPherron et al., 1997) . These technical advances and the existence of a rare highly fecund sheep breed in China encouraged us to explore the possibility of downregulation of the activity of MSTN gene by gene targeting whereby a sheep with merits of both multiple births and well-developed muscle might be created. The MSTN gene is a tissue-specific expressed gene and is expressed constantly in skeletal muscles. This pattern of gene expression facilitates the use of a promoter-trap strategy to detect targeting events using easily detected markers or simple gene expression analysis. In addition, homology of targeted loci could lead to a distinct phenotype in animals and this would certainly be helpful in selecting and characterising targeted animals.
In this paper, we report cloning of ovine MSTN gene, construction of promoter trap gene-targeting vectors, isolation and culture of ovine primary myoblast cells, and production and characterisation of targeted cells. A scheme for rescuing the targeted cells by nuclear transfer is under way. Isolation of MSTN DNA China Han ovine genomic DNA was isolated from blood by conventional methodology. A 6.0 kb MSTN gene fragment was obtained by long polymerase chain reaction (PCR) from genomic DNA preparations and was cloned into the pMD-18T vector (Takara Bio Inc., Tokyo, Japan).
Material and methods

Animals
Construction of gene-targeting vector
The promoter trap vector MSTN-neo comprised a 5.0-kb fragment of the MSTN gene containing exon 1, intron 1, exon 2 and intron 2, and a portion of exon 3 was the long arm for homologous recombination; a 0.8 kb XbaI-BamHI (Takara) fragment of neomycin marker gene derived from pEGFP-N1 (Promega Corp., Madison, WI, USA) was the selective marker; an 1.0 kb BamHI-KpnI (Takara) fragment containing a portion of exon 3 and the 3 0 -end region of the MSTN gene was the short arm for homologous recombination. These fragments were cloned into the pGEM-3Zf (2) (Promega) vector. The final gene-targeting vector MSTNneo was constructed by inserting successively the three DNA fragments into the KpnI-XbaI (Takara) site of the cloning vector. Linear vector DNA molecules were produced by cutting the vector at the unique AatII (Takara) site and were used for transfection of ovine myoblast cells in culture. The vector MSTN-green fluorescent protein (GFP ) was constructed in a similar way except that the selection marker neomycin was replaced by GFP.
Preparation of primary ovine myoblast cells Samples of ovine skeletal muscle were removed from the hind limb of a male foetus (50 days old) and from a neonatal (3 to 5 days old) lamb. The muscle tissue was dissected free from skin and bone. The remaining muscle mass was weighed, and a few drops of phosphate-buffered saline (PBS) were added and the muscle was minced into a coarse slurry using razor blades. Cells were enzymatically dissociated by 0.25% trypsin (GIBCO BRL, Gaithersburg, MD, USA) solution for 15 min. The slurry, maintained at 378C for 30 to 45 min, was titrated 15 times with a 5-ml plastic pipette and then passed through a 80 mm nylon mesh (Nitex; Tetko, Inc., Monterey Park, CA, USA). The filtrate was spun at 350 g to sediment the dissociated cells, the pellet was resuspended in growth medium and the suspension was plated on collagen-coated dishes. During the first several passages of the primary cultures, myoblasts were enriched by preplating (Richler and Yaffe, 1970) .
Growth medium for primary myoblasts consisted of Ham's F-10 Nutrient mixture (GIBCO BRL) supplemented with 15% foetal bovine serum (FBS) (HyClone Laboratories, Inc., Logan, UT, USA) and 2.5 ng/ml bFGF (Promega). All media contained penicillin G (200 U/ml) and streptomycin (200 mg/ml). Tissue culture plastic dishes were coated with 0.01% type I collagen (Sigma Chemical Co., St Louis, MO, USA). DMEM (Invitrogen, Carlbad, CA, USA) growth medium supplement with 20% FBS (HyClone) was used as a negative control for enriching the primary myoblast cells. Cells were grown in a humidified incubator at 378C in 5% CO 2 .
In the process of early culture (primary passage 30-40 h), differential attachment technique was used to gain enriched myoblast cells. Cells were washed with PBS (Ca 21 free), and enzymatically dissociated using 0.25% trypsin solution until the cells contracted and detached from the dish. The desegregation was stopped by adding growth medium and the collected cells were replated in the plastic plates. After 40 min incubation, most non-myogenic cells, such as fibroblasts, adhered to the dish, while most myoblasts were still in the suspension. The myoblasts were then collected and seeded into new culture vessels. 5 ovine skeletal cells or foetal skeletal muscles cells were seeded in each 35-mm plate and transfected the next day with 4 mg linear MSTN-neo, using lipofectAMINE (Invitrogen), according to the maufacturer's protocol. Fortyeight hours after transfection, G418 selection (700 mg/ml) was applied for 10-15 days. For comparing the effect of serum on drug selection, 15%, 20% and 25% FBS were used in the culture medium (a total of 127 neo-resistant colonies were generated).
Immunofluorescent staining of desmin Cells from the clones were fixed in 2% formaldehyde in PBS for 5 min at room temperature followed by 100% methanol at 2208C for 5 min. The cells were then rinsed in PBS. All further incubations were carried out at room temperature and all rinses and dilutions were with a blocking solution consisting of 2% horse serum and 0.5% Triton-X 100 in PBS. An initial blocking step was performed with this solution for 30 min. An antibody to desmin (rabbit polyclonal, Sigma) was applied for 30 min at a dilution of 1:400. After rinsing, a fluorescein-coupled secondary antibody (1/250, Amersham Pharmacia Biotech, London, UK) was applied for 30 min. The cells were rinsed and stained with the bisbenzirnide dye, HOECHST 33342 (Invitrogen), at 0.2 mmol/l in PBS for 15 min to stain individual nuclei.
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The percentage of myogenic cells was determined microscopically as the ratio of desmin-expressing cells to the total number of cells in 10 randomly chosen fields at a magnification of 2503.
Nucleic acid analysis PCR. Homologous recombination events were detected by PCR amplification across the 3 0 -end short-arm homology. The position of PCR primers is shown in Figure 1 and the two primer sequences for MSTN-neo were primer 1: 5 0 -CTC CTTTCTTCAGGTGCATTTTTAC-3 0 ; primer 2: 5 0 -GATTGTCTGT TGTGCCCAGTCATAG-3 0 . The PCR cycling parameters used were as follows: step 1: 958C/5 min; step 2: 948C/30 s; step 3: 568C/40 s; step 4: 728C/2 min; step 5: 728C/10 min; step 6: 48C/10 min and steps 2 to 4 were repeated for 35 times. The two primers for MSTN-GFP were named primer 3 and primer 4 and the sequence of primer 4 was 5 0 -TGAAG CACTGCACGCCGTAGGTCAG-3. Primer 3 sequence was the same as primer 1 and the PCR cycling parameters were the same as for MSTN-neo, except that step 3 was 588C/40 s. PCR products were analysed by agarose gel electrophoresis.
Southern analysis. For Southern analysis of MSTN gene targeting, the genomic DNA was isolated from cell clones via standard technique. Genomic DNA (10 mg) was digested with restriction enzymes (Takara) and then size fractionated via electophoresis within a 0.8% agarose gel. DNA was then transferred to a nylon membrane (Amersham) via capillary action in 20 3 SSC (3 mol/l NaC1, 75 mmol/l Na citrate pH 7.0). Southern hybridisation was performed using 32 P-labelling and detection system (Bio-Rad Laboratories Inc., Hercules, CA, USA). The molecular probe was a 900 bp ovine MSTN 3 0 gene fragment adjacent to but outside the 3 0 homologous short arm.
RT-PCR. Total RNA from these positive clones verified by PCR or Southern blotting was extracted using Trizol (Invitrogen), according to the manufacturer's protocol. Firststrand cDNA was synthesised in 0.5 ml reverse transcriptase reaction from 200 ng of total RNA using an RT-PCR kit (Takara). PCR was performed with 2 ml of the RT reaction at 948C/20 s, 538C/30 s and 728C/45 s, 30 cycles were used. The primers (Figure 1 ) used to amplify 225 bp ovine MSTN were P1: 5 0 -G AAGTCAAGGTAACAGACACACC-3 0 and P2: 3 0 -GTGCACAAGATGGGTATGAGGATA-5 0 . The RT-PCR products were resolved on an agarose gel and analysed using Multi-analyst software (Bio-Rad).
DNA sequencing
The RT-PCR product DNA fragment from positive cell clones, verified by Southern blotting or RT-PCR, was retrieved and cloned into the pMD-18T vector (Takara) and sequenced. The nucleotide sequence was blasted to the DNA sequence in GeneBank. The DNA sequence from successful targeting would include part of the exon 3 sequence of MSTN followed by the selective gene (GFP or Neo) sequence ( Figure 6 ).
Western bolt analysis
Myoblasts from these positive clones were cultured as described above in 100 mm dishes. Cells (4 3 10 6 ) were washed with PBS two times prior to being resuspended in 200 ml lysis buffer and sonicated. The cell extracts were centrifuged to pellet the cell debris, and the suspernatants were frozen at 2808C. Bradford reagent (Bio-Rad) was used to estimate total protein content to ensure equal loadings. Precisely, 15 mg of total protein was separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) (12%) and transferred onto nitrocellulose membrane by electroblotting. The membrane was blocked in TBST/5% milk at 48C overnight and then incubated with primary antibody for 3 h at room temperature. A 1 : 1000 dilution of purified rabbit anti-MSTN (Sigma) and a 1 : 3000 dilution of purified mouse monoclonal anti-b-actin (Sigma) were the respective primary antibodies used in the western blot. The membranes were washed with TBST and further incubated with anti-rabbit IgG HRP conjugate, 1 : 2000 dilution (Promega), secondary antibodies for 1 h at room temperature. The membranes were washed as above, and HPR activity was detected using Western blot chemiluminescence (Promega). Equal protein concentrations were quantified relative to b-actin.
Results
Myoblasts appeared to have a selective growth advantage and became the predominant cell type in the culture, accounting for more than 95% of the cell population within 2 weeks. Also, we used differential attachment techniques to enrich the myoblast cells from the fibroblast-dominated one. The two cell populations were distinguished by staining for the intermediate filament protein desmin, which is expressed only in myogenic cells (Kaufman and Foster, 1988) .
After several passages, one dish was fixed and stained with an anti-desmin antibody to identify myogenic cells. We showed that the isolated cell clones were still myogenic cells. For the cultures shown in Figure 2 , cells grown in F-10 were highly enriched (100%) for myogenic cells. On the other hand, growth of primary cultures in DMEM supplemented with 20% foetal calf serum resulted in infibroblastenriched populations in which less than 2% of the cells expressed desmin.
In order to identify visibly the rare homologous recombination events, MSTN-GFP, a promoter trap vector, was used in the initial experiment. In this vector, GFP gene coding sequence, from initiation codon to stop codon, was inserted in frame to replace part of the third exon of MSTN gene. This strategy would avoid the marker gene from being expressed by random integration at many loci and in most cases the positive cells would result from the rare homologous recombination events. In our experiments, primary myoblast cells from neonatal ovine tissue after seven passages were transfected with the MSTN-GFP vector DNA and 4 3 10 6 cells were transfected totally. We could detect, on average, three to four fluorescent cells per 10 5 cells 24 h posttransfection (Figure 3a) . The cells were separated by fluorescence-activated cell sorting and used for PCR assay after limited proliferation (Figure 3b and c) . We generated 34 fluorescent clones to gain enough DNA for PCR. The two primers are shown in Figure 1 . The forward primer (primer 2, F1) was homologous to a sequence located within GFP gene and the reverse primer (primer 1, F2) was complementary to an external sequence located downstream of the short arm. The positive label was the 1.5 kb fragment.
RT-PCR analysis of cell clones MSTN-GFP is shown in Figure 5 while the two primers are shown in Figure 1 . The primers were located on either side of each targeted loci, one upstream of exon 3 and the other located downstream from exon 3. Successfully targeted clones were positive for the 956 bp label. Non-homologous insertions of MSTN-GFP vector resulted in no GFP expression, and were positive for the wild-form MSTN PCR product of 225 bp ( Figure 5 ).
DNA sequence of RT-PCR product from positive cell clones was taken to verify the gene targeted done (Figure 6 ). DNA sequencing of positive clones showed a 63-bp sequence of exon 3 followed by the marker gene GFP sequence. This indicated that the 114 bp MSTN exon 3 sequence was replaced by the GFP sequence. The genetargeting efficiency of the MSTN-GFP promoter trap vector was 8/34 (23.5%).
In subsequent experiments, another promoter trap vector MSTN-neo was used. The structure of the MSTN-neo vector was very much the same as MSTN-GFP. Neo cassette was inserted to replace a portion of the exon 3 of MSTN gene and this substitution would delete some conserved cysteine residues, which in turn would result in a mutated protein in place of the normal MSTN protein. About 4 3 10 6 foetal ovine myoblast cells were transfected with the MSTN-neo vector DNA. After G418 screening, cell clones were grown. During the process of G418 screening, foetal cells were divided into three groups and allowed to grow in three media containing 15%, 20% and 25% FBS, respectively. Results showed (Table 1) that more cell clones were generated from medium containing 20% FBS. In total, 127 clones were proliferated to enough cell mass in order to extracting genomic DNA for PCR detection and Southern analysis. After that we transfected 4 3 10 6 myoblast cells from neonatal China-Han sheep with MSTN-neo vector DNA. During the process of G418 screening, we use medium containing 20% FBS and generated 136 clones for the next analysis.
After 30 days of cell culture, clones surviving G418 screening were assayed by PCR. The forward primer (primer 2) was homologous to a sequence located within neo gene and the reverse primer (primer 1) was complementary to an external sequence located downstream of the short arm. The location of the two primers designed almost same with the vector MSTN-GFP, so the primers shown with F1 and F2 in Figure 1 . Using this design, the targeted allele yielded a 1.6 kb DNA fragment and the normal allele yielded no product (Figure 4a) .
To confirm the targeting of homologous recombination events, Southern blotting analysis was preformed using genomic DNA from PCR-positive cell clones. Samples were digested by SphI and XbaI (Takara) and were probed with the untransfected sequence down the short homologous arm. Identification of the myoblast cell targeted with MSTNneo is illustrated in Figure 4b . The results showed that a 5.2 kb fragment was detected in all samples, which come from the normal MSTN locus and one clone showed a 1.2-kb fragment spanning the targeting locus. This is consistent with the presence of one target and one normal MSTN allele.
RT-PCR was preformed to verify the myosatin gene expression disorder ( Figure 5 ). The design of two primers was the same for MSTN-GFP (Figure 1) . The successfully targeted clone showed the 1020 bp label, and non-homologous insertions of the MSTN-neo vector showed no Neo expression and were positive for the wild-form MSTN PCR product of 225 bp (Figure 6 ).
DNA sequence of RT-PCR product from the positive cell clone was taken to verify the gene targeted done increasingly ( Figure 5 ). The result showed the 63 bp DNA sequence of exon 3 followed the marker gene neo, and which indicated that the 114 bp nucleotide sequence of MSTN exon 3 was replaced by the marker gene neo gene.
To characterise the expression of MSTN protein, we performed Western blot analyses on protein extracts prepared from myoblast cell clones after the above molecular detection. Anti-MSTN antibodies specifically detect two bands on the Western blot (Figure 7 ). These two bands correspond with the unprocessed full-length protein (52 kDa) and the N-terminal LAP (latency-associated peptide, 40 kDa). Positive myoblast clones were detected although the two bands were very blurred compared with non-positive myoblast clones. We found that the MSTN unprocessed fulllength protein and LAP levels in negative clones were 7.40 and 7.77 times as much as the levels in positive clones, respectively. The densitometry data of MSTN protein demonstrated that MSTN protein expression was strongly downregulated in gene-targeted myoblast clones.
Discussion
Recent advances in studies on functions of the MSTN gene and on gene targeting in somatic cells have made it possible to knockout the MSTN gene in cultured cells. We chose myogenic precursor cells as gene-target recipients because of their ability to proliferate in culture.
The mature muscle cells of the mammalian skeleton, known as myofibres, are multinucleated syncytia that arise from the fusion of mononucleated precursors or myoblasts. We sought to obtain enriched populations of myoblasts from primary cultures of ovine skeletal muscle, which were mixtures of myoblasts and fibroblasts. To overcome the problem of fibroblast overgrowth, we used F-10 nutrient media and obtained more than 95% of the cell population within 2 weeks. This myogenic enrichment increased further with time in culture. One reason for the improved growth of myoblasts in F-10 compared with the other nutrient mixtures was the low rate of spontaneous myoblast differentiation in F-10. Second, we used bFGF that stimulated the growth of primary myoblasts (Rando and Blau, 1994) to a greater extent than did other growth factors. The lifespan of primary myoblast cell in culture is limited and screening targeted cell clones are impossible by the methods used successfully in stem cell lines. The culture conditions described above, optimised for the enrichment of primary myoblasts, also allowed the cloning of myoblasts from primary cultures.
For successful targeting of somatic cells, the most important issue is to detect the rare homologous recombination events as early as possible. We constructed promoter trap vectors to avoid prolonged screening and to improve targeting efficiency. The design used the transcriptional machinery of the endogenous target gene to drive the positive selection. Thus, most random insertions would not activate signals encoded by marker gene constructs, MSTN-GFP and MSTN-neo. Typically, promoter trap selection will yield an enrichment of about 100-fold for targeted clones and should work well with both replacement and insertion vectors (Schwartzberg et al., 1990) . In our experiments, the targeting efficiency as indicated by GFP-expressing cells or G418-resistant clones was in the range of efficiencies reported in the literature (McCreath et al., 2000) . A systematic evaluation of the biological parameters that govern the selection process showed that a successful strategy must match the expression level of the target gene, the efficacy of marker and the selection stringency (Hanson and Sedivy, 1995) . Targeting (2000) with primary fibroblast cells. Thus, putative candidate cells can be produced in a reproducible manner and this will facilitate rescue of targeted cells by nuclear transfer. The GFP-positive cells were proliferated, preserved and used in nuclear transfer.
It has been shown that many cell colonies become senescent following G418 screening (Denning et al., 2001) and that DNA transfection and drug screening influenced the capacity of cell proliferation and passages. Besides, myoblast primary cells are more sensitive to factors in cell culture than fibroblast cells. These data indicate that the chance for success of gene targeting in myoblast cells is lower than in some other cell types.
A cell-rescue scheme has been designed and carried out, by which selected positive cells would be colonised via nuclear transfer (data not shown). It was hoped that a cloned foetus or even a lamb would produce enough new materials that could be used for assay at the molecular level and for experiments designed to knockout the opposite allele.
In conclusion, modification of the MSTN gene is possible by gene targeting in foetal or neonatal ovine primary myoblast cells with a type of promoter trap vector. Sitespecific recombination elements, for example lox P, should be used to flank marker gene for facilitating the deletion of the marker gene before the production of targeted animals by nuclear transfer. 
